• leader board size
Consumer Research2020-11-05T23:41:25-08:00

Consumer Research

Optimi Ships Psilocybin to the UK for Phase 2 Trial

VANCOUVER – Optimi Health Corp. announced it has completed its first export of naturally derived psilocybin to the United Kingdom, with the material earmarked for a planned Phase 2 clinical trial whose partner and therapeutic ...

Vireo Growth Initiates Share Consolidation

MINNEAPOLIS – Vireo Growth Inc. continues to adjust its capital structure as it integrates recent acquisitions and positions itself among larger players in the U.S. Сannabis market. The company announced it will consolidate its multiple ...

Argentina Lawmakers Float Full Cannabis Legalization Plan

BUENOS AIRES – Argentina's lower house of Congress received a comprehensive Cannabis legalization bill, introduced by left-wing national deputies Myriam Bregman and Nicolás del Caño. The legislation would make Cannabis and all its derivatives fully ...

Cross-Border Deals Now Define Cannabis M&A

LOS ANGELES – The global Cannabis industry has entered a new phase, one where the most influential deals are no longer being struck in North America, but across continents. The month of June kicked off ...

Fluent Offloads Pennsylvania Dispensaries

NEW YORK – Fluent Corp. has finalized the sale of its three Pennsylvania dispensaries to HIVE Holdings Inc. for $12.5 million in cash, marking a deliberate shift toward debt reduction and operational efficiency. The deal ...

DEA Increases Psychedelics Production Quotas for 2026

WASHINGTON – The Drug Enforcement Administration has approved expanded production limits for key psychedelics, setting the stage for increased scientific inquiry into substances like psilocybin and DMT next year. In a final order published Monday ...

Wyld Acquires Grön

SEATTLE – Wyld, a leading producer of THC-CBD-infused gummies and chocolates, announced its agreement to acquire Grön, a Portland-based maker of sugar-coated pearls and confections, in a move that unites two prominent players in the ...

Week in Review: Cannabis & Psychedelics Industry Highlights

LOS ANGELES – Federal rescheduling under President Trump’s Executive Order sparked widespread state reactions and investor outlooks into early 2026, blending consolidations and expansions with regulatory friction, outright manipulation, and overtures to public opinion. Psychedelics ...

California Allocates $30M in Cannabis Research Grants

SACRAMENTO – California's Department of Cannabis Control has disbursed nearly $30 million to support 22 academic projects examining Cannabis's influence on public health, environmental practices, and the regulated market. The funding, drawn from taxes on ...

Atai Gains Nasdaq Biotechnology Index Spot

NEW YORK – AtaiBeckley N.V., the clinical-stage biopharmaceutical firm born from the November merger of atai Life Sciences and Beckley Psytech, has secured a place in the Nasdaq Biotechnology Index (NBI), a move that underscores ...

Subscribe To Our Newsletter

Go to Top